K201814: BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K201814 (BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer, cleared 2020-09-28 for Becton, Dickinson and Company) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K201814
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK201814
Cleared Device Trade / Generic NameBD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2, 4-3-3 and 4-3-5 optical configurations), BD FACSDuet Sample Preparation System, BD FACS Univer
FDA Applicant on FilingBecton, Dickinson and Company
FDA 3-Letter Product ClassificationProduct Code OYE
FDA Substantial Equivalence Decision Date2020-09-28
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Becton, Dickinson and Company, compare peer devices under FDA Product Code OYE, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.